Lv62
2300 积分 2024-03-18 加入
Antibody–Bottlebrush Conjugates Unlock Diverse Payloads for Targeted Cancer Therapy
26天前
已完结
Anlotinib enhanced CD8+ T cell infiltration via induction of CCL5 improves the efficacy of PD-1/PD-L1 blockade therapy in lung cancer
28天前
已完结
Novel Therapeutic Strategies for Metastatic Prostate Cancer Care
1个月前
已完结
Pharmacokinetics of trastuzumab deruxtecan (T-DXd), a novel anti-HER2 antibody-drug conjugate, in HER2-positive tumour-bearing mice
1个月前
已完结
Mild Method for Deprotection of the N-Benzyloxycarbonyl (N-Cbz) Group by the Combination of AlCl3 and HFIP
2个月前
已完结
Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody–Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers
3个月前
已完结
Comparative expression of trophoblast cell-surface antigen 2 (TROP2) in the different molecular subtypes of invasive breast carcinoma: An immunohistochemical study of 94 therapy-naive primary breast tumors
3个月前
已完结
Sacituzumab govitecan for hormone receptor–positive HER2-negative advanced breast cancer
3个月前
已完结
Next-generation antibody-drug conjugates for breast cancer: Moving beyond HER2 and TROP2
3个月前
已完结
Discovery of 8-(6-Methoxypyridin-3-yl)-1-(4-(piperazin-1-yl)-3-(trifluoromethyl)phenyl)-1,5-dihydro-4H-[1,2,3]triazolo[4,5-c]quinolin-4-one (CQ211) as a Highly Potent and Selective RIOK2 Inhibitor
4个月前
已完结
皖公网安备34019202002308
